Advertisement
Screener

ORAGENICS, INC. (OGEN) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

0.9 / 5 stars · 10/53 Roast Me

ORAGENICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

ORAGENICS, INC. (OGEN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 9.14 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.

Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-03-16

  • ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-12-31 was 45.90K shares.
  • ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-09-30 was 0.00 shares.
  • ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-06-30 was 1.75K shares.
  • ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-03-31 was 2.92K shares.
  • ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 9.14K shares, a 81.93% decline from fiscal 2024.
  • ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 50.56K shares, a 31.12% increase from fiscal 2023.
  • ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 38.56K shares, a 73.76% increase from fiscal 2022.
  • ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 22.19K shares, a 96.52% decline from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed
2025-12-319.14K shares
10-K · filed 2026-03-16
2024-12-3145.90K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14
45.90K shares
derived: sum of 2 quarters · filed 2025-03-14
47.64K shares
derived: sum of 3 quarters · filed 2025-03-14
50.56K shares
10-K · filed 2025-03-14
2024-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
1.75K shares
derived: sum of 2 quarters · filed 2024-11-13
4.67K shares
10-Q · filed 2024-11-13
2024-06-301.75K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
4.67K shares
10-Q · filed 2024-08-09
2024-03-312.92K shares
10-Q · filed 2024-05-15
2023-12-3138.56K shares
10-K · filed 2024-03-29
2022-12-31-704.81K shares
derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-04-17
-704.81K shares
derived: sum of 2 quarters · filed 2023-04-17
-32.31K shares
derived: sum of 3 quarters · filed 2023-04-17
22.19K shares
10-K · filed 2023-04-17
2022-09-300.00 shares
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2023-04-14
672.50K shares
derived: sum of 2 quarters · filed 2023-04-14
727.00K shares
10-Q/A · filed 2023-04-14
852.26K shares
derived: sum of 4 quarters · filed 2023-04-14
2022-06-30672.50K shares
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2023-04-14
727.00K shares
10-Q/A · filed 2023-04-14
852.26K shares
derived: sum of 3 quarters · filed 2023-04-14
948.06K shares
derived: sum of 4 quarters · filed 2023-04-14
2022-03-3154.50K shares
10-Q/A · filed 2023-04-14
179.76K shares
derived: sum of 2 quarters · filed 2023-04-14
275.56K shares
derived: sum of 3 quarters · filed 2023-04-14
2021-12-31125.26K shares
derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-29
221.06K shares
derived: sum of 2 quarters · filed 2022-07-29
638.23K shares
10-K/A · filed 2022-07-29
2021-09-3095.80K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
512.97K shares
10-Q · filed 2021-11-15
2021-06-30417.17K shares
10-Q · filed 2021-08-16
2020-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
0.00 shares
derived: sum of 2 quarters · filed 2021-03-01
1.00K shares
10-K · filed 2021-03-01
2020-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10
1.00K shares
10-Q · filed 2020-11-10
2020-06-301.00K shares
10-Q · filed 2020-08-14
2019-12-311.93K shares
10-K · filed 2020-03-04
2018-12-311.50K shares
10-K · filed 2019-03-29
2018-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13
0.00 shares
10-Q · filed 2018-08-13
-64.08K shares
derived: sum of 3 quarters · filed 2019-03-29
7.12K shares
derived: sum of 4 quarters · filed 2019-03-29
2018-03-310.00 shares
10-Q · filed 2018-05-15
-64.08K shares
derived: sum of 2 quarters · filed 2019-03-29
7.12K shares
derived: sum of 3 quarters · filed 2019-03-29
7.12K shares
derived: sum of 4 quarters · filed 2019-03-29
2017-12-31-64.08K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
7.12K shares
derived: sum of 2 quarters · filed 2019-03-29
7.12K shares
derived: sum of 3 quarters · filed 2019-03-29
7.12K shares
10-K · filed 2019-03-29
2017-09-3071.20K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31
71.20K shares
derived: sum of 2 quarters · filed 2017-10-31
71.20K shares
10-Q · filed 2017-10-31
-446.08K shares
derived: sum of 4 quarters · filed 2018-02-16
2017-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
0.00 shares
10-Q · filed 2017-08-14
-517.28K shares
derived: sum of 3 quarters · filed 2018-02-16
-315.86K shares
derived: sum of 4 quarters · filed 2018-02-16
2017-03-310.00 shares
10-Q · filed 2017-05-15
-517.28K shares
derived: sum of 2 quarters · filed 2018-02-16
-315.86K shares
derived: sum of 3 quarters · filed 2018-02-16
57.48K shares
derived: sum of 4 quarters · filed 2018-02-16
2016-12-31-517.28K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16
-315.86K shares
derived: sum of 2 quarters · filed 2018-02-16
57.48K shares
derived: sum of 3 quarters · filed 2018-02-16
57.48K shares
10-K · filed 2018-02-16
574.76K shares
10-K · filed 2017-02-27
2016-09-30201.43K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
574.76K shares
derived: sum of 2 quarters · filed 2016-11-14
574.76K shares
10-Q · filed 2016-11-14
574.76K shares
derived: sum of 4 quarters · filed 2017-02-27
2016-06-30373.33K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15
373.33K shares
10-Q · filed 2016-08-15
373.33K shares
derived: sum of 3 quarters · filed 2017-02-27
373.33K shares
derived: sum of 4 quarters · filed 2017-02-27
2016-03-310.00 shares
10-Q · filed 2016-05-16
0.00 shares
derived: sum of 2 quarters · filed 2017-02-27
0.00 shares
derived: sum of 3 quarters · filed 2017-02-27
198.33K shares
derived: sum of 4 quarters · filed 2017-02-27
2015-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
0.00 shares
derived: sum of 2 quarters · filed 2017-02-27
198.33K shares
derived: sum of 3 quarters · filed 2017-02-27
278.33K shares
10-K · filed 2017-02-27
2015-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
198.33K shares
derived: sum of 2 quarters · filed 2015-11-06
278.33K shares
10-Q · filed 2015-11-06
311.67K shares
derived: sum of 4 quarters · filed 2016-03-30
2015-06-30198.33K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07
278.33K shares
10-Q · filed 2015-08-07
311.67K shares
derived: sum of 3 quarters · filed 2016-03-30
311.67K shares
derived: sum of 4 quarters · filed 2016-03-30
2015-03-3180.00K shares
10-Q · filed 2015-05-08
113.33K shares
derived: sum of 2 quarters · filed 2016-03-30
113.33K shares
derived: sum of 3 quarters · filed 2016-03-30
113.33K shares
derived: sum of 4 quarters · filed 2016-03-30
2014-12-3133.33K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
33.33K shares
derived: sum of 2 quarters · filed 2016-03-30
33.33K shares
derived: sum of 3 quarters · filed 2016-03-30
70.47K shares
10-K · filed 2016-03-30
2014-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03
0.00 shares
derived: sum of 2 quarters · filed 2014-11-03
37.14K shares
10-Q · filed 2014-11-03
37.14K shares
derived: sum of 4 quarters · filed 2015-02-27
2014-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
37.14K shares
10-Q · filed 2014-08-07
37.14K shares
derived: sum of 3 quarters · filed 2015-02-27
67.14K shares
derived: sum of 4 quarters · filed 2015-02-27
2014-03-3137.14K shares
10-Q · filed 2014-05-09
37.14K shares
derived: sum of 2 quarters · filed 2015-02-27
67.14K shares
derived: sum of 3 quarters · filed 2015-02-27
67.14K shares
derived: sum of 4 quarters · filed 2015-02-27
2013-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
30.00K shares
derived: sum of 2 quarters · filed 2015-02-27
30.00K shares
derived: sum of 3 quarters · filed 2015-02-27
56.05K shares
10-K · filed 2015-02-27
2013-09-3030.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-25
30.00K shares
derived: sum of 2 quarters · filed 2013-10-25
56.05K shares
10-Q · filed 2013-10-25
2013-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12
26.05K shares
10-Q · filed 2013-08-12
2013-03-3126.05K shares
10-Q · filed 2013-05-15
2012-12-31164.75K shares
10-K · filed 2014-02-28
2011-12-31151.16K shares
10-K · filed 2013-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
Nexentis Technologies Inc. (NXTS)$0.002B
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Genprex, Inc. (GNPX)United States$0.003B-0.02